OsteoVantage was awarded a US $0.15MM SBIR Phase I grant. Funds will support enhancements to INDOS™, a spinal instrumentation system that employs electroactive pedicle screws to encourage posterolateral fusion.
Johnson & Johnson (JNJ), parent company of DePuy Synthes, will undertake restructuring actions in its Medical Devices business, including changes to the orthopaedics segment. JNJ cited business exits and staff reductions as it seeks pre-tax cost savings of up to $1 billion by end of 2018.
As you prepare to attend the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, we present to you a list of first-time exhibitors with product development initiatives that you may find of interest.
AlloSource was awarded U.S. Patent No. 9,186,253, Cartilage mosaic compositions and methods, for its ProChondrix® Cartilage Restoration Matrix allograft product.
OrthAlign successfully completed limited release of the OrthAlign Plus® for Total Hip Arthroplasty device for use in the direct anterior approach. The product will commence full launch at the AAOS Annual Meeting in March 2016.
Bone Therapeutics commenced a Phase IIA study for the treatment of multiple delayed-union fractures with ALLOB® allogeneic bone cell therapy product.Â